Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib in Giant Cell Arteritis (M16-852, Japan)
jRCT2080224537Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jan 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in giant cell arteritis (GCA) comparing Upadacitinib arm with Placebo arm (2 arms). Started Jan 2019; status: completed.
02
Drugs
upadacitinib
03
Conditions
giant cell arteritis (GCA)
Beyond the preview
Go deeper on jRCT2080224537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224537.